Investigation of low-dose ritonavir on human peripheral blood mononuclear cells using gene expression whole genome microarrays

Genomics

Volumn 96, Issue 1, 2010, Pages 57-65

  Yilmaz, Saliha ^a   Boffito, Marta ^b   Collot Teixeira, Sophie ^a   De Lorenzo, Ferruccio ^b   Waters, Laura ^b   Fletcher, Carl ^b   Back, David ^c   Pozniak, Anton ^b   Gazzard, Brian ^b   McGregor, John Louis ^a,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Bioinformatics; Biomarker; Gene expression microarray; PBMC; Ritonavir

Indexed keywords

BIOLOGICAL MARKER; KELCH DOMAIN CONTAINING 3 PROTEIN; LONG CHAIN FATTY ACID COENZYME A LIGASE SHORT CHAIN FAMILY MEMBER 2; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NEUTRAL CHOLESTEROL ESTER HYDROLASE 1; RITONAVIR; UNCLASSIFIED DRUG; ACETYL COENZYME A SYNTHETASE; CARBOXYLESTERASE; DUSP1 PROTEIN, HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; NCEH1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATION; LIPID METABOLISM; LOW DRUG DOSE; MALE; MICROARRAY ANALYSIS; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ADOLESCENT; BIOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ACETATE-COA LIGASE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 1; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIV PROTEASE INHIBITORS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RITONAVIR;

EID: 77953811724     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2010.03.011     Document Type: Article

References (32)

1. De Clercq E. Anti-HIV drugs: 25 compounds approved within 25years after the discovery of HIV. Int. J. Antimicrob. Agents 2008.
2. Gatti G., et al. The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring. AIDS 1999, 13(15):2083-2089.
3. Gazzard B., et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med. 2006, 7(8):487-503.
4. Currier J.S., et al. Coronary heart disease in HIV-infected individuals. J. Acquir. Immune. Defic. Syndr. 2003, 33(4):506-512.
5. Shafran S.D., Mashinter L.D., Roberts S.E. The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations. HIV Med 2005, 6(6):421-425.
6. Collot-Teixeira S., et al. Impact of Different Low-Dose Ritonavir Regimens on Lipids, CD36, and Adipophilin Expression. Clin. Pharmacol. Ther. 2008.
7. Adler-Wailes D.C., et al. Effects of ritonavir on adipocyte gene expression: evidence for a stress-related response. Obesity (Silver Spring) 2008, 16(10):2379-2387.
8. Parker R.A., et al. Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors. Mol. Pharmacol. 2005, 67(6):1909-1919.
9. Malizia A.P., et al. HIV1 protease inhibitors selectively induce inflammatory chemokine expression in primary human osteoblasts. Antiviral Res. 2007, 74(1):72-76.
10. Lum P.Y., et al. Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia. Genomics 2007, 90(4):464-473.
11. Lin Y.W., Yang J.L. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J. Biol. Chem. 2006, 281(2):915-926.
12. Ewing R.M., et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 2007, 3:89.
13. Min K.W., et al. TIP120A associates with cullins and modulates ubiquitin ligase activity. J. Biol. Chem. 2003, 278(18):15905-15910.
14. Goldenberg S.J., et al. Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases. Cell 2004, 119(4):517-528.
15. Zheng J., et al. CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. Mol. Cell. 2002, 10(6):1519-1526.
16. Wyss S., et al. The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter]. J. Virol. 2001, 75(6):2982-2992.
17. Fu W., et al. Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res. 2008.
18. Jang K.L., Collins M.K., Latchman D.S. The human immunodeficiency virus tat protein increases the transcription of human Alu repeated sequences by increasing the activity of the cellular transcription factor TFIIIC. J. Acquir. Immune. Defic. Syndr. 1992, 5(11):1142-1147.
19. Chiang K.P., et al. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chem. Biol. 2006, 13(10):1041-1050.
20. Okazaki H., et al. Identification of neutral cholesterol ester hydrolase, a key enzyme removing cholesterol from macrophages. J. Biol. Chem. 2008, 283(48):33357-33364.
21. Zakkar M., et al. Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ. Res. 2008, 103(7):726-732.
22. Kang J.G., et al. Genomic analysis of circulating cells: a window into atherosclerosis. Trends Cardiovasc. Med. 2006, 16(5):163-168.
23. Ohinata Y., Sutou S., Mitsui Y. A novel testis-specific RAG2-like protein Peas: its expression in pachytene spermatocyte cytoplasm and meiotic chromatin. FEBS Lett. 2003, 537(1-3):1-5.
24. Altschul S.F., et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25(17):3389-3402.
25. Maeda Y., et al. CUL2 is required for the activity of hypoxia-inducible factor and vasculogenesis. J. Biol. Chem. 2008, 283(23):16084-16092.
26. Mahrour N., et al. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J. Biol. Chem. 2008, 283(12):8005-8013.
27. Lewis S., Ashburner M., Reese M.G. Annotating eukaryote genomes. Curr. Opin. Struct. Biol. 2000, 10(3):349-354.
28. Ashburner M., et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25(1):25-29.
29. Lin S.M., et al. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 2008, 36(2):e11.
30. Wright G.W., Simon R.M. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003, 19(18):2448-2455.
31. Pavlidis P., Lewis D.P., Noble W.S. Exploring gene expression data with class scores. Pac. Symp. Biocomput. 2002, 474-485.
32. Shannon P., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13(11):2498-2504.